Lexicon Pharmaceuticals (LXRX) Competitor Comparison
We are evaluating the key criteria listed to compare Lexicon Pharmaceuticals (LXRX) against its competitors in the Biotechnology industry.
Market Capitalization
156 / 368Gross Profits
200 / 278Total Revenue
250 / 300EBITDA
254 / 337Free Cashflow
261 / 352Quick Ratio
138 / 357Earnings per Share
106 / 359Dividend yield
0 / 6Total Cash
146 / 358Performance 3 years
236 / 368Performance 5 years
209 / 368Performance 10 years
235 / 368Linearity 3 years
181 / 368Linearity 5 years
151 / 368Linearity 10 years
111 / 368Total Rank
329 / 368Dividend Rank
187 / 368Valuation Rank
364 / 368Piotroski Rank
293 / 368Muliplier Rank
139 / 368Gross Profits - LXRX ranking 200 / 278
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.